Sang Ho Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sang Ho Lee has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Byungkyu Kim
Department of Mechanical and Aerospace Engineering, Korea Aerospace University, 200-1 Hwajeon dong, Deogyang-gu, Goyang-city, Gyeonggi-do, 412-791, Korea
3 shared publications Su Hong
Division of Life Sciences and Biotechnology Korea University, Seoul, Republic of Korea
3 shared publicationsSung Sik Choi
Division of Life Sciences and Biotechnology Korea University, Seoul, Republic of Korea
3 shared publicationsC. N. Hwang
Korea University
2 shared publicationsDong Ho Lee
Korea University
2 shared publicationsEun Jin Kim
Division of Life Sciences, Korea University, Seoul, Republic of Korea
2 shared publications
Latest Publications
- 7 May 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (5) , 2355-2364
Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells
Background/Aim: It is necessary to select an appropriate strategy that makes cancer cells more sensitive to chemotherapeutic drug(s). The aim of this study was to further explore the mechanism(s) behind drug sensitization in the breast cancer MCF7 cell line using 5-azacytidine (AzaC) pretreatment in doxorubicin (Dox) chemotherapy. Materials and Methods: Cells were treated with either AzaC or Dox alone or in combination (AzaC+Dox) for 24 and 48 h. Cells were also pretreated with AzaC for a week before replacement with Dox at varying concentrations in another group of experiments (AzaC/Dox) for 24 and 48 h. The cells in the groups were subjected to cytochemical analyses, including 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide (MTT), intracellular reactive oxygen species (ROS) and cell death by dual staining with Hoechst33342 (Hoechst) and propidium iodide (PI). Cells were also analyzed for determining specific alterations of possible target proteins by western blot. Results: Compared to a single (AzaC and Dox) or simultaneous drug exposure (AzaC+Dox), cellular activity was significantly reduced in AzaC/Dox group of cells in a dose- and time-dependent manner (p<0.05). The clonogenic potential of cells was also significantly inhibited in AzaC/Dox compared to Dox and AzaC group after 7 days (p<0.05). The rates of ROS-generated and PI-stained cells were significantly higher in the AzaC+Dox and AzaC/Dox groups compared to those of individual drug groups at 48 h (p<0.05). These observations were accompanied by activation of ERK1/2 and p38MAPK, as well as up-regulation of BAX and P53 in the AzaC/Dox group. However, the levels of BCL-2 were down-regulated in Dox and AzaC+Dox among a different group of cells. Elevated levels of activated caspase-3 were observed only in AzaC/Dox group of cells. The levels of phospho-nuclear factor-kappa B (pNF-ĸB)(Thr) decreased with increasing dosage of Dox in different groups, while down-regulation of heat shock protein 70 (HSP70) was observed only in the AzaC+Dox group of cells. Conclusion: AzaC significantly increases the sensitivity of MCF7 cells to Dox via activation of ERK1/2, P53, BAX and caspase-3. Moreover, the inhibition of pNF-ĸB(Thr) and HSP70 might also contribute to an increase in the sensitivity of MCF7 cells to Dox.
- 7 May 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (5) , 2355-2364
Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells
Background/Aim: It is necessary to select an appropriate strategy that makes cancer cells more sensitive to chemotherapeutic drug(s). The aim of this study was to further explore the mechanism(s) behind drug sensitization in the breast cancer MCF7 cell line using 5-azacytidine (AzaC) pretreatment in doxorubicin (Dox) chemotherapy. Materials and Methods: Cells were treated with either AzaC or Dox alone or in combination (AzaC+Dox) for 24 and 48 h. Cells were also pretreated with AzaC for a week before replacement with Dox at varying concentrations in another group of experiments (AzaC/Dox) for 24 and 48 h. The cells in the groups were subjected to cytochemical analyses, including 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide (MTT), intracellular reactive oxygen species (ROS) and cell death by dual staining with Hoechst33342 (Hoechst) and propidium iodide (PI). Cells were also analyzed for determining specific alterations of possible target proteins by western blot. Results: Compared to a single (AzaC and Dox) or simultaneous drug exposure (AzaC+Dox), cellular activity was significantly reduced in AzaC/Dox group of cells in a dose- and time-dependent manner (p<0.05). The clonogenic potential of cells was also significantly inhibited in AzaC/Dox compared to Dox and AzaC group after 7 days (p<0.05). The rates of ROS-generated and PI-stained cells were significantly higher in the AzaC+Dox and AzaC/Dox groups compared to those of individual drug groups at 48 h (p<0.05). These observations were accompanied by activation of ERK1/2 and p38MAPK, as well as up-regulation of BAX and P53 in the AzaC/Dox group. However, the levels of BCL-2 were down-regulated in Dox and AzaC+Dox among a different group of cells. Elevated levels of activated caspase-3 were observed only in AzaC/Dox group of cells. The levels of phospho-nuclear factor-kappa B (pNF-ĸB)(Thr) decreased with increasing dosage of Dox in different groups, while down-regulation of heat shock protein 70 (HSP70) was observed only in the AzaC+Dox group of cells. Conclusion: AzaC significantly increases the sensitivity of MCF7 cells to Dox via activation of ERK1/2, P53, BAX and caspase-3. Moreover, the inhibition of pNF-ĸB(Thr) and HSP70 might also contribute to an increase in the sensitivity of MCF7 cells to Dox.
- 7 May 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (5) , 2343-2354
Heterogeneous Cell Types in Single-cell-derived Clones of MCF7 and MDA-MB-231 Cells
Background/Aim: Variations in cell phenotype in a single-cell-derived clone may result from asymmetric cell divisions that lead to different cell fate in a homogenous microenvironment. The aim of this study was to demonstrate the extent of cell variety in single-cell-derived clones and propose a different strategy in treating cancer by observed phenotypic heterogeneity in cellular types. Additionally, the role of metabolic enzyme and housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in cellular phenotype was evaluated in two breast cancer cell lines. Materials and Methods: Two GAPDH-overexpressing breast cancer cell lines, MCF7-GAPDH-RFP (MCF7-RFP) and MDA-MB-231-GAPDH-RFP (MDA-RFP), were established. Microscopic recordings were made at 12-h intervals in single-cell-derived clones of both cell lines up to 8-10 days. Crystal violet and Hoechst 33342 (Hoechst), as well as specific cell-type (epithelial and mesenchymal) antibodies, were used for cytochemical and immunohistochemical staining analyses, respectively, at 3, 6 and 9 days during cell growth. Results: Three types of clones with distinct morphologies were identified as holo-, mero- and paraclones. The rates of colony survival during cell growth were 8.3 and 41.7% in MCF7-RFP and MDA-RFP, respectively. Although no significant difference was found in the colony forming efficiency (CFE) of both MCF7 and MDA-MD-231 wild-type cells, a markedly significant difference was seen in the CFE of MCF7-RFP and MDA-RFP cells (p=0.001). Wild-type cell-derived holoclones of both cell lines showed drug resistance to doxorubicin (Dox). However, levels of proliferating cell nuclear antigen (PCNA) and vimentin (VIM) marginally decreased in Dox-treated clones. Furthermore, high level of intraclonal heterogeneity was found for CD44, CD140a, VIM, fibronectin (FN), focal adhesion kinase (FAK), paxillin (PXN) and vinculin (VCL) in MCF7 and MDA clones during different stages of clonal development. Expressions of CD140a, FN, VIM and FAK were induced in GAPDH-red fluorescent protein (RFP)-tagged clones of both cell lines. Conclusion: The GAPDH-RFP recombinant protein played an important role in morphological heterogeneity detection in early stages of clonal development. Moreover, phenotypic heterogeneity in clones, caused by the cells expressing specific antigens, such as CD44, CD140a, FN, VIM, FAK and VCL, can be the right target for therapeutic drugs.
- 7 May 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (5) , 2343-2354
Heterogeneous Cell Types in Single-cell-derived Clones of MCF7 and MDA-MB-231 Cells
Background/Aim: Variations in cell phenotype in a single-cell-derived clone may result from asymmetric cell divisions that lead to different cell fate in a homogenous microenvironment. The aim of this study was to demonstrate the extent of cell variety in single-cell-derived clones and propose a different strategy in treating cancer by observed phenotypic heterogeneity in cellular types. Additionally, the role of metabolic enzyme and housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in cellular phenotype was evaluated in two breast cancer cell lines. Materials and Methods: Two GAPDH-overexpressing breast cancer cell lines, MCF7-GAPDH-RFP (MCF7-RFP) and MDA-MB-231-GAPDH-RFP (MDA-RFP), were established. Microscopic recordings were made at 12-h intervals in single-cell-derived clones of both cell lines up to 8-10 days. Crystal violet and Hoechst 33342 (Hoechst), as well as specific cell-type (epithelial and mesenchymal) antibodies, were used for cytochemical and immunohistochemical staining analyses, respectively, at 3, 6 and 9 days during cell growth. Results: Three types of clones with distinct morphologies were identified as holo-, mero- and paraclones. The rates of colony survival during cell growth were 8.3 and 41.7% in MCF7-RFP and MDA-RFP, respectively. Although no significant difference was found in the colony forming efficiency (CFE) of both MCF7 and MDA-MD-231 wild-type cells, a markedly significant difference was seen in the CFE of MCF7-RFP and MDA-RFP cells (p=0.001). Wild-type cell-derived holoclones of both cell lines showed drug resistance to doxorubicin (Dox). However, levels of proliferating cell nuclear antigen (PCNA) and vimentin (VIM) marginally decreased in Dox-treated clones. Furthermore, high level of intraclonal heterogeneity was found for CD44, CD140a, VIM, fibronectin (FN), focal adhesion kinase (FAK), paxillin (PXN) and vinculin (VCL) in MCF7 and MDA clones during different stages of clonal development. Expressions of CD140a, FN, VIM and FAK were induced in GAPDH-red fluorescent protein (RFP)-tagged clones of both cell lines. Conclusion: The GAPDH-RFP recombinant protein played an important role in morphological heterogeneity detection in early stages of clonal development. Moreover, phenotypic heterogeneity in clones, caused by the cells expressing specific antigens, such as CD44, CD140a, FN, VIM, FAK and VCL, can be the right target for therapeutic drugs.
- Open Access
- 8 November 2013
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (4) , 998-1011
Dominant Role of Peroxiredoxin/JNK Axis in Stemness Regulation During Neurogenesis from Embryonic Stem Cells
Redox balance has been suggested as an important determinant of “stemness” in embryonic stem cells (ESCs). In this study, we demonstrate that peroxiredoxin (Prx) plays a pivotal role in maintenance of ESC stemness during neurogenesis through suppression of reactive oxygen species (ROS)-sensitive signaling. During neurogenesis, Prx I and Oct4 are expressed in a mutually dependent manner and their expression is abruptly downregulated by an excess of ROS. Thus, in Prx I−/− or Prx II−/− ESCs, rapid loss of stemness can occur due to spontaneous ROS overload, leading to their active commitment into neurons; however, stemness is restored by the addition of an antioxidant or an inhibitor of c-Jun N-terminal kinase (JNK). In addition, Prx I and Prx II appear to have a tight association with the mechanism underlying the protection of ESC stemness in developing teratomas. These results suggest that Prx functions as a protector of ESC stemness by opposing ROS/JNK cascades during neurogenesis. Therefore, our findings have important implications for understanding of maintenance of ESC stemness through involvement of antioxidant enzymes and may lead to development of an alternative stem cell-based therapeutic strategy for production of high-quality neurons in large quantity. Stem Cells 2014;32:998–1011
- 8 November 2013
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (4) , 998-1011
Open AccessDominant Role of Peroxiredoxin/JNK Axis in Stemness Regulation During Neurogenesis from Embryonic Stem Cells
Redox balance has been suggested as an important determinant of “stemness” in embryonic stem cells (ESCs). In this study, we demonstrate that peroxiredoxin (Prx) plays a pivotal role in maintenance of ESC stemness during neurogenesis through suppression of reactive oxygen species (ROS)-sensitive signaling. During neurogenesis, Prx I and Oct4 are expressed in a mutually dependent manner and their expression is abruptly downregulated by an excess of ROS. Thus, in Prx I−/− or Prx II−/− ESCs, rapid loss of stemness can occur due to spontaneous ROS overload, leading to their active commitment into neurons; however, stemness is restored by the addition of an antioxidant or an inhibitor of c-Jun N-terminal kinase (JNK). In addition, Prx I and Prx II appear to have a tight association with the mechanism underlying the protection of ESC stemness in developing teratomas. These results suggest that Prx functions as a protector of ESC stemness by opposing ROS/JNK cascades during neurogenesis. Therefore, our findings have important implications for understanding of maintenance of ESC stemness through involvement of antioxidant enzymes and may lead to development of an alternative stem cell-based therapeutic strategy for production of high-quality neurons in large quantity. Stem Cells 2014;32:998–1011
- 5 December 2012
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 44 (1) , 47-54
Expression and regulation of SNAP-25 and synaptotagmin VII in developing mouse ovarian follicles via the FSH receptor
Soluble-NSF attachment protein receptor (SNARE) proteins play a role in vesicle fusion, exocytosis, and intracellular trafficking in neuronal cells as well as in fertilization and embryogenesis. We investigated the expression patterns of two SNARE proteins, SNAP-25 and synaptotagmin VII (SytVII), and their regulation by pregnant mare serum gonadotropin (PMSG) during mouse ovarian follicular development. Ovaries were obtained at 0, 12, 24, 36, and 48 h post-PMSG injection of immature mice. SNAP-25 and SytVII mRNA expression levels increased gradually in a time-dependant manner. However, protein levels revealed different patterns of expression, suggesting different translational regulation following PMSG stimulation. SNAP-25 and SytVII expression was closely associated with thickening of the granulosa cell (GC) layer and follicle morphological changes from a flattened to a cuboidal shape. To explore follicle stimulating hormone receptor (FSHR)-mediated regulation of their expression, GCs from preantral follicles were cultured to examine the effects of FSHR siRNA knockdown. FSHR siRNA abolished upregulation of the SNAREs in both PMSG and FSH-stimulated GCs. This abolished gene expression was rescued by adding dibutyryl cyclic AMP to the cultures. These results suggest that SNAP-25 and SytVII expression is regulated via the FSHR-cAMP pathway during follicular development.
- 5 December 2012
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 44 (1) , 47-54
Expression and regulation of SNAP-25 and synaptotagmin VII in developing mouse ovarian follicles via the FSH receptor
Soluble-NSF attachment protein receptor (SNARE) proteins play a role in vesicle fusion, exocytosis, and intracellular trafficking in neuronal cells as well as in fertilization and embryogenesis. We investigated the expression patterns of two SNARE proteins, SNAP-25 and synaptotagmin VII (SytVII), and their regulation by pregnant mare serum gonadotropin (PMSG) during mouse ovarian follicular development. Ovaries were obtained at 0, 12, 24, 36, and 48 h post-PMSG injection of immature mice. SNAP-25 and SytVII mRNA expression levels increased gradually in a time-dependant manner. However, protein levels revealed different patterns of expression, suggesting different translational regulation following PMSG stimulation. SNAP-25 and SytVII expression was closely associated with thickening of the granulosa cell (GC) layer and follicle morphological changes from a flattened to a cuboidal shape. To explore follicle stimulating hormone receptor (FSHR)-mediated regulation of their expression, GCs from preantral follicles were cultured to examine the effects of FSHR siRNA knockdown. FSHR siRNA abolished upregulation of the SNAREs in both PMSG and FSH-stimulated GCs. This abolished gene expression was rescued by adding dibutyryl cyclic AMP to the cultures. These results suggest that SNAP-25 and SytVII expression is regulated via the FSHR-cAMP pathway during follicular development.
- 31 August 2012
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 21 (4) , 1195-1201
Blueberry protects LPS-stimulated BV-2 microglia through inhibiting activities of p38 MAPK and ERK1/2
- 31 August 2012
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 21 (4) , 1195-1201
Blueberry protects LPS-stimulated BV-2 microglia through inhibiting activities of p38 MAPK and ERK1/2
- 12 October 2009
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 395 (7) , 2415-2421
Droplet-based magnetically activated cell separation: analysis of separation efficiency based on the variation of flow-induced circulation in a pendent drop
- 12 October 2009
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 395 (7) , 2415-2421
Droplet-based magnetically activated cell separation: analysis of separation efficiency based on the variation of flow-induced circulation in a pendent drop
- 1 October 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 470-473
Design and Application of a DEP-based Cell Sorter, for Efficiently Separating Two Types of Human MCF Cells
This paper presents the development of a novel dielectrophoresis (DEP)-activated cell sorter (DACS) that has 3D-asymmeritc microelectrodes. The DACS conventionally utilizes relative strength between the DEP and drag forces. While the conventional cell separators usually depend on different size of cells, the new system differentiates similarly-sized cells by the difference of the electrical properties among cells. It distinguished different types of cells by their differences in electrical properties, conductivity and permittivity. Thus, continuously varying DEP forces generated by the system enabled us to separate MCF10A cells (normal cells derived from human breast epithelium) and MCF7 cells (human breast cancer cells) that have similar sizes. Applying the newly-developed system to separate two different cells, it was possible to separate cancer cells among normal cells.
- 1 October 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 470-473
Design and Application of a DEP-based Cell Sorter, for Efficiently Separating Two Types of Human MCF Cells
This paper presents the development of a novel dielectrophoresis (DEP)-activated cell sorter (DACS) that has 3D-asymmeritc microelectrodes. The DACS conventionally utilizes relative strength between the DEP and drag forces. While the conventional cell separators usually depend on different size of cells, the new system differentiates similarly-sized cells by the difference of the electrical properties among cells. It distinguished different types of cells by their differences in electrical properties, conductivity and permittivity. Thus, continuously varying DEP forces generated by the system enabled us to separate MCF10A cells (normal cells derived from human breast epithelium) and MCF7 cells (human breast cancer cells) that have similar sizes. Applying the newly-developed system to separate two different cells, it was possible to separate cancer cells among normal cells.
- 1 October 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 162-165
Droplet-based Magnetically Activated Cell Separator (DMACS): Evaluation of separation efficiency versus variance of magnetic flux density
We introduced a droplet-based magnetically activated cell separator (DMACS) that utilizes a hanging droplet of microliter-sized volume for dividing positive (magnetically labeled) and negative (magnetically unlabeled) cells. It enabled us to solve adhesion problem in channel and showed better separation efficiency. However, the separation efficiency was changed under variations of initial volume (the droplet volume of cell suspension before buffer injection process for dividing the hanging droplet into two fractions). Therefore, the efficiencies corresponding to initial volumes were investigated in experimental study. We found that the initial volume should be optimized to find maximum separation efficiency.
- 1 October 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 162-165
Droplet-based Magnetically Activated Cell Separator (DMACS): Evaluation of separation efficiency versus variance of magnetic flux density
We introduced a droplet-based magnetically activated cell separator (DMACS) that utilizes a hanging droplet of microliter-sized volume for dividing positive (magnetically labeled) and negative (magnetically unlabeled) cells. It enabled us to solve adhesion problem in channel and showed better separation efficiency. However, the separation efficiency was changed under variations of initial volume (the droplet volume of cell suspension before buffer injection process for dividing the hanging droplet into two fractions). Therefore, the efficiencies corresponding to initial volumes were investigated in experimental study. We found that the initial volume should be optimized to find maximum separation efficiency.
- Open Access
- 21 September 2006
- Published by Springer Nature in Biotechnology Letters
- Vol. 28 (22) , 1865
Dual reporter genes enabling cell tracing with viable and reliable selection of various cell types
- 21 September 2006
- Published by Springer Nature in Biotechnology Letters
- Vol. 28 (22) , 1865
Open AccessDual reporter genes enabling cell tracing with viable and reliable selection of various cell types
- 1 March 2006
- Published by Springer Nature in Biotechnology Letters
- Vol. 28 (5) , 287-293
Dual Reporter Genes Enabling Cell Tracing with Viable and Reliable Selection of Various Cell Types
- 1 March 2006
- Published by Springer Nature in Biotechnology Letters
- Vol. 28 (5) , 287-293
Dual Reporter Genes Enabling Cell Tracing with Viable and Reliable Selection of Various Cell Types